The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Repare Therapeutics Inc. (RPTX) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $14.71. The Repare Therapeutics Inc. has recorded 2,418 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Repare Therapeutics Insiders Establish Automatic Securities Disposition Plans.
Repare Therapeutics Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $14.71 and fluctuated between $15.38 as its day high and $14.39 as its day low. The current market capitalization of Repare Therapeutics Inc. is $634.00M. A total of 0.29 million shares were traded on the day, compared to an average of 161.29K shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, RPTX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 33 BUYs and 34 SELLs from insiders. Insiders purchased 3,719,230 shares during that period but sold 4,654,003.
In the most recent transaction, Jerel Davis sold 250,000 shares of RPTX for 16.00 per share on Dec 09. After the transaction, the Director now owns 2,094,451 company shares. In a previous transaction on Jun 13, BVF PARTNERS L P/IL bought 149,161 shares at 12.73 per share. RPTX shares that 10% Owner owns now total 4,443,423.
Among the insiders who bought shares, BVF PARTNERS L P/IL acquired of 6,869 shares on Jun 06 at a per-share price of $13.21. This resulted in the 10% Owner holding 4,368,757 shares of RPTX after the transaction. In another insider transaction, BVF PARTNERS L P/IL bought 644,044 shares at $12.29 per share on Jun 03. Company shares held by the 10% Owner now total 4,364,948.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for RPTX in the last 3 months, the mean price target is $26.00 with high estimates of $31.00 and low estimates of $13.00. In terms of 52-week highs and lows, RPTX has a high of $22.20 and a low of $8.06.
As of this writing, RPTX has an earnings estimate of -$0.89 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.83 per share and a lower estimate of -$0.97. The company reported an EPS of -$0.83 in the last quarter, which was 3.50% higher than expectations of -$0.86.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 8 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RPTX is Overweight with a score of 4.71. A total of 7 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.